Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen Says Places 10 NanoChip Sytems in Third Quarter

NEW YORK, Oct. 3 – Microarray technology developer Nanogen said Wednesday that it had sold seven of its NanoChip Molecular Biology Workstations during the quarter and placed another three through non-title transfer agreements to development site partners.

Nanogen said that it has placed 40 of its SNP scoring workstations to unnamed customers and collaborators.

Howard Birndorf, Nanogen’s founder and executive chairman, said that the company decided to make the announcement in light of the current economic downturn.

“I'm pleased to report that our title transfer transactions recorded as product revenue more than tripled over the last quarter, keeping us on track to meet our year-end placement goals and revenue forecasts," Birndorf said in a statement.

Nanogen’s microarray technology uses a matrix of 100 charged pads to immobilize strands of DNA to perform assays. It is designed to investigate SNPs, short tandem repeats, insertions, and deletions. 

On Tuesday, Nanogen competitor Sequenom announced that it had sold 10 of its MassArray gene analysis systems to a variety of companies and institutions during the third quarter. Sequenom said it has sold 48 systems to date.


The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.